「小普日報」2023年1月4日熱點速遞

#今日行業(yè)熱點#
?
①The EMBO Journal:細(xì)胞膜形態(tài)決定了IgM B細(xì)胞抗原受體簇的三維動態(tài)定位
DOI :10.15252/embj.2022112030
②Separation and Purification Technology:抗COVID-19潛在藥物千金藤堿的提取、純化和鑒定現(xiàn)狀與挑戰(zhàn)
DOI :10.1016/j.seppur.2022.123038
③American Journal of Hematology:使用polatuzumab vedotin和ventoclax靶向MCL-1和BCL-2克服R/R NHL的治療耐藥性:來自臨床前模型和Ib期研究的結(jié)果
DOI :10.1002/ajh.26809
④Theranostics:靶向WWP1通過抑制KLF15-泛素化介導(dǎo)的心肌炎癥來改善心臟缺血損傷
DOI :10.7150/thno.77694
⑤Bulletin of the World Health Organization:基于盧旺達(dá)地區(qū)的乳腺癌分子診斷:免疫組織化學(xué)與新型GeneXpert? mRNA表達(dá)測定的成本最小化研究
Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert? mRNA expression assay
DOI :10.2471/BLT.22.288800
⑥American Journal of Hematology:Hematopoietic stem cell donor vaccination with CMV Triplex augments frequencies of functional and durable CMV-specific T cells in the recipient: a novel strategy to limit antiviral prophylaxis
DOI :10.1002/ajh.26824
⑦Emerging Microbes & Infections:SARS-CoV-2 Omicron亞系的交叉中和和病毒適應(yīng)度
DOI :10.1080/22221751.2022.2161422
⑧創(chuàng)勝集團用于治療實體瘤同類首創(chuàng)靶向Gremlin1抗體TST003臨床試驗申請獲國家藥監(jiān)局批準(zhǔn)
⑨國務(wù)院聯(lián)防聯(lián)控機制:咳嗽是機體的保護(hù)性反射,本身不會引起肺炎
⑩國家衛(wèi)健委:我國疫情防控工作重心從“防感染”轉(zhuǎn)向“保健康、防重癥”
?
普健生物提醒各位朋友,疫情期間勤洗手,戴口罩,少聚集,常通風(fēng),養(yǎng)成健康生活方式!?